Live From Dr. Sean, The Hidden Fat Your Doctor Never Looks For
In a Nutshell
Dr. Shawn's session spotlights BRP, a natural peptide discovered via AI that reduces food intake by 50% and strips fat from obese mice without the GI or muscle-loss side effects of GLP-1 drugs like Ozempic. Unlike synthetic Ozempic, BRP acts only in the hypothalamus, is produced by the body itself, and leaves muscle intact while improving glucose tolerance. The broader message is that viewing food as a source of precise biological signals—rather than calories or vitamins—plus targeting hidden visceral fat via diet, fermentation, and MRI-guided strategies, can produce rapid, drug-free metabolic change.
These notes were generated by AI and may contain inaccuracies.
Dr. Shawn conducts live sessions every Wednesday evening across multiple platforms including X, YouTube, Facebook, and Instagram. The session focuses on peptides and features discussion of a new study on a powerful peptide called BRP from Stanford research published in Nature.
Dr. Shawn maintains a conservative approach to peptides despite acknowledging their significant potential. He states he is "super conservative and super natural" in his approach, noting that while these substances represent "some of the most exciting potentiators of change in human beings," long-term effects remain unknown. He reserves the right to change his position but currently maintains cautious distance and does not recommend them to others.
The Stanford study examined BRP peptide with the following key findings:
- Lean mice received a single intramuscular injection of BRP before meals, resulting in up to 50% reduction in food intake over the subsequent hour
- Obese mice received daily injections for 14 days and lost an average of 3 grams, almost entirely from fat
- Control mice gained approximately 3 grams during the same period
- Treated mice showed improved glucose and insulin tolerance
The study did not distinguish between types of fat lost - whether visceral, cardiac, intramuscular, or subcutaneous - leaving this critical detail unknown.
BRP operates through a fundamentally different pathway than synthetic GLP-1 medications like Ozempic. BRP works through receptors in the brain hypothalamus, while Ozempic acts on GLP-1 receptors throughout the body. This difference results in fewer side effects with BRP, avoiding common GLP-1 side effects including:
Sign in to read the full notes
Get access to AI-generated notes, topic timestamps, and more.